BNC2-AS1: A Potential Drug Target Or Biomarker (G111216284)
BNC2-AS1: A Potential Drug Target Or Biomarker
BNC2-AS1 (RP11-62F24.2), a protein that is expressed in human tissues, has been identified as a potential drug target or biomarker. The protein is a key regulator of the cell cycle, and its dysfunction has been linked to various diseases, including cancer.
The BNC2-AS1 protein is a member of the BNC2 gene family, which is known for its role in the regulation of cell cycle progression. The BNC2-AS1 protein is a 21-kDa protein that is expressed in various human tissues, including muscle, liver, and brain.
One of the key functions of the BNC2-AS1 protein is its role in the regulation of G1 phase of the cell cycle. During G1, the cell prepares for cell division by producing necessary organelles and proteins. The BNC2-AS1 protein plays a critical role in regulating the length of the G1 phase and the amount of time that the cell spends in this phase.
In addition to its role in regulating the cell cycle, the BNC2-AS1 protein has also been linked to the development and progression of various diseases. For example, studies have shown that BNC2-AS1 is overexpressed in various cancer tissues, including breast, ovarian, and colorectal cancers. This suggests that the BNC2-AS1 protein may be a useful biomarker or drug target in these diseases.
Furthermore, the BNC2-AS1 protein has also been shown to be involved in the regulation of cell adhesion. Adhesion is the process by which cells stick together and form tissues. The BNC2-AS1 protein plays a critical role in regulating cell-cell adhesion by maintaining the integrity of the actin filaments that are involved in adhesion.
The BNC2-AS1 protein is also involved in the regulation of cell migration. During cell migration, cells move from one location to another along the body's surface. The BNC2-AS1 protein plays a critical role in regulating the movement of cells along the surface of the body, allowing them to move in a specific direction and reach their destination.
In conclusion, the BNC2-AS1 protein is a key regulator of the cell cycle and has been linked to the development and progression of various diseases. Its potential as a drug target or biomarker makes it an attractive target for future research. Further studies are needed to fully understand the role of the BNC2-AS1 protein in the regulation of cell biology and to determine its potential as a therapeutic agent.
Protein Name: BNC2 Antisense RNA 1
More Common Targets
BNIP1 | BNIP2 | BNIP3 | BNIP3L | BNIP5 | BNIPL | BOC | BOD1 | BOD1L1 | BOD1L2 | BOK | BOK-AS1 | BOLA1 | BOLA2 | BOLA2B | BOLA3 | BOLA3-DT | BOLL | Bombesin receptor | Bone morphogenetic protein (BMP) | Bone Morphogenetic Protein Receptor | Bone Morphogenetic Protein Receptor Type I | BOP1 | BORA | BORCS5 | BORCS6 | BORCS7 | BORCS7-ASMT | BORCS8 | BORCS8-MEF2B | BPESC1 | BPGM | BPHL | BPI | BPIFA1 | BPIFA2 | BPIFA3 | BPIFA4P | BPIFB1 | BPIFB2 | BPIFB3 | BPIFB4 | BPIFB5P | BPIFB6 | BPIFC | BPNT1 | BPNT2 | BPTF | BPY2 | Bradykinin receptor | BRAF | BRAFP1 | Branched-chain alpha-ketoacid dehydrogenase (BCKD) complex | BRAP | BRAT1 | BRCA1 | BRCA1-A complex | BRCA1-BRCA2-containing complex | BRCA1P1 | BRCA2 | BRCC3 | BRD1 | BRD2 | BRD3 | BRD3OS | BRD4 | BRD7 | BRD7P3 | BRD8 | BRD9 | BRDT | BRF1 | BRF2 | BRI3 | BRI3BP | BRI3P1 | BRI3P2 | BRICD5 | BRINP1 | BRINP2 | BRINP3 | BRIP1 | BRISC complex | BRIX1 | BRK1 | BRME1 | BRMS1 | BRMS1L | Bromodomain adjacent to zinc finger domain protein | Bromodomain-containing protein | BROX | BRPF1 | BRPF3 | BRS3 | BRSK1 | BRSK2 | BRWD1 | BRWD1 intronic transcript 2 (non-protein coding) | BRWD1-AS2 | BRWD3